OmniAb, Inc. (OABI) Dividend History

OmniAb, Inc. is a biotechnology company focused on developing and licensing innovative antibody discovery platforms. The company’s technology enables the creation of next-generation therapeutic antibodies, primarily serving the biopharmaceutical industry in drug discovery and development.

5980 Horton Street, Emeryville, CA, 94608
Phone: 510-250-7800
Website: https://www.omniab.com

Dividend History

OmniAb, Inc. currently does not pay dividends

Company News

AI Is Quietly Reinventing Healthcare--And Real Deployments Are Now Underway

AI is transforming healthcare through innovative technologies like disease screening, genetic testing, antibody discovery, and drug development platforms, with several companies making significant technological advancements in medical AI applications.

Benzinga

Featured Companies: RXRX TEM TVGN
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

VERAXA Biotech and OmniAb have entered a co-discovery alliance to develop a novel bispecific antibody drug conjugate program targeting solid tumors. The partnership combines VERAXA's ADC technology with OmniAb's antibody discovery solutions.

GlobeNewswire Inc.

Featured Companies: VACH
USANA Health Sciences (USNA) Q1 Earnings and Revenues Top Estimates

USANA Health (USNA) delivered earnings and revenue surprises of 24.64% and 2.03%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research

Featured Companies: USNA
7 Hot Penny Stocks To Buy In May According To Insiders

Penny stocks to buy according to 7 insiders in May 2023. The post 7 Hot Penny Stocks To Buy In May According To Insiders appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

PennyStocks

Featured Companies: ESPR SOND SWIM TLS

Page data last updated 07/23/2025 16:21:56 UTC